Insights into pegRNA design from editing of the cardiomyopathy-associated phospholamban R14del mutation

Publication date

2025-09

Authors

Yao, Bing
Yang, Qiangbing
Snijders Blok, Christian J B
Daniels, Mark A.
Doevendans, PieterISNI 0000000110574516
Schiffelers, RaymondORCID 0000-0002-1012-9815ISNI 0000000045237985
Sluijter, JoostORCID 0000-0003-2088-9102ISNI 0000000392195257
Lei, Zhiyong

Editors

Advisors

Supervisors

Document Type

Article

Collections

Open Access logo

License

cc_by

Abstract

Prime editing (PE) represents a transformative genome-editing technology and enables precise insertions, deletions, and base substitutions without introducing double-strand breaks, thereby reducing undesired indels and off-target effects. Despite advancements in enhanced prime editors and optimized prime editing guide RNAs (pegRNAs), designing effective pegRNAs remains a major challenge. The phospholamban (PLN) R14del mutation is associated with cardiomyopathies, making it a crucial target for precise gene-editing strategies. In this study, we explored pegRNA features that contribute to high editing efficiency using the FluoPEER.PLN R14del reporter cell line. Through systematic screening, we identified three pegRNAs with significantly enhanced editing efficiency. Our findings underscore the importance of pegRNA secondary structure and stability in optimizing prime editing, providing valuable insights into precise gene correction strategies.

Keywords

PLN R14del mutation, Phospholamban, gene therapy, pegRNA optimization, prime editing, Biophysics, Structural Biology, Biochemistry, Molecular Biology, Genetics, Cell Biology

Citation

Yao, B, Yang, Q, Snijders Blok, C J B, Daniels, M A, Doevendans, P A, Schiffelers, R, Sluijter, J P G & Lei, Z 2025, 'Insights into pegRNA design from editing of the cardiomyopathy-associated phospholamban R14del mutation', FEBS letters, vol. 599, no. 17, pp. 2543-2554. https://doi.org/10.1002/1873-3468.70097